Is Berkshire The Best Stock to Buy in a Bad Market?
Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…
Sell
28
MOLN Quote, Financials, Valuation and Earnings
Last price:
$4.27
Seasonality move
:
16.44%
Day range:
$4.08 - $4.15
52-week range:
$3.36 - $12.70
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
20.42x
P/B ratio:
0.96x
Volume:
2.1K
Avg. volume:
19.1K
1-year change:
2.51%
Market cap:
$150.4M
Revenue:
$5.6M
EPS (TTM):
-$1.81
Earnings Data
Next earnings date for MOLN
Aug 25
2025
Most recent earnings per share
-$0.34
Beat by $0.11
(Mar 7/2025)
Consensus Estimate
-$0.45
(Mar 7/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MOLN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/25/2025 | Q2 | -- | -- | -- | -$0.43 | -- |
| 03/31/2025 | Q1 | -- | -- | -- | -$0.42 | -- |
| 03/07/2025 | Q4 | -- | -- | -$0.34 | -$0.45 | $0.11 |
| 09/30/2024 | Q3 | -- | $787.5K | -$0.57 | -$0.63 | $0.06 |
| 08/26/2024 | Q2 | -- | $1.7M | -$0.51 | -- | -- |
| 03/31/2024 | Q1 | $1.4M | $3.1M | -$0.39 | -- | -- |
| 03/15/2024 | Q4 | -- | $1.2M | -$0.68 | -- | -- |
| 09/30/2023 | Q3 | -- | $2.9M | -$0.40 | -- | -- |
| 08/25/2023 | Q2 | -- | $461.7K | -$0.55 | -- | -- |
| 03/31/2023 | Q1 | -- | $3.3M | -$0.49 | -- | -- |
| 03/09/2023 | Q4 | -- | $2.8M | -$0.56 | -- | -- |
| 09/30/2022 | Q3 | -- | $2.4M | -$0.42 | -- | -- |
| 08/25/2022 | Q2 | -- | $12.2M | -$0.15 | -- | -- |
| 03/31/2022 | Q1 | -- | $187.1M | $5.00 | -- | -- |
| 12/31/2021 | Q4 | -- | $1.9M | -$0.61 | -- | -- |
| 09/30/2021 | Q3 | -- | $3.8M | -$0.41 | -- | -- |
| 08/26/2021 | Q2 | -- | $3.5M | -$0.61 | -- | -- |
| 03/31/2021 | Q1 | -- | $901K | -$0.63 | -- | -- |
| 12/31/2020 | Q4 | -- | $1.7M | -$0.85 | -- | -- |
| 09/30/2020 | Q3 | -- | $307.8K | -$0.65 | -- | -- |
Molecular Partners AG Earnings Questions
-
How Much did Molecular Partners AG Generate in Revenue Last Quarter?
Molecular Partners AG reported -- worth of top line sales in its most recent quarter.
-
Did Molecular Partners AG Beat Earnings Last Quarter?
Molecular Partners AG announced earnings per share of -$0.34 which represents a beat of analyst forecast a -$0.45 per share.
-
Is Molecular Partners AG Profitable?
Molecular Partners AG reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Molecular Partners AG EPS Next Year?
Molecular Partners AG's earnings are forecast to decrease from -$1.81 per share to -$1.81 per share next year representing a decrease of -4.75%.
-
When is Molecular Partners AG's Earnings Date?
Molecular Partners AG's next earnings date is August 25, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
The big picture trends in e‑commerce sales are clearly in…
Is RTX The Best Growth Stock?
Among the worldwide aerospace and defense markets, the US controls…
Stock Ideas
Buy
71
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
63
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
60
RGC alert for May 6
Regencell Bioscience Holdings [RGC] is up 113.25% over the past day.
Buy
63
SKX alert for May 6
Skechers USA [SKX] is down 0.02% over the past day.
Sell
20
PTCT alert for May 6
PTC Therapeutics [PTCT] is down 10.85% over the past day.
